Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 1.98B | $ 1.48B | $ 1.84B | $ 1.67B | $ 1.48B |
Total Assets | $ 18.75B | $ 15.24B | $ 14.87B | $ 13.97B | $ 14.73B |
Total Debt | $ 4.88B | $ 4.03B | $ 4.48B | $ 4.43B | $ 4.72B |
Net Debt | $ 2.89B | $ 2.55B | $ 2.64B | $ 2.76B | $ 3.24B |
Total Liabilities | $ 12.84B | $ 9.85B | $ 9.95B | $ 9.36B | $ 9.92B |
Stockholders Equity | $ 5.87B | $ 5.36B | $ 4.89B | $ 4.58B | $ 4.79B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |